Female Sexual Arousal Disorder Clinical Trial
Official title:
A Double Blind, Placebo Controlled 2-way Cross-over Study to Assess the Clitoral Engorgement Response as Measured by Non-contrast Magnetic Resonance Imaging (MRI) in Women With Female Sexual Arousal Disorder (FSAD) When Administered a Single Dose of Sildenafil (100mg) Followed by Audio/Visual Sexual Stimulation
The purpose of this study is to investigate the effect of 100 mg sildenafil on clitoral engorgement in pre-menopausal women, as well as examining the safety and toleration of the drug.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03820453 -
Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women.
|
N/A | |
| Completed |
NCT02958176 -
Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
|
N/A | |
| Terminated |
NCT00572377 -
Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
|
Phase 1 | |
| Recruiting |
NCT04948151 -
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
|
Phase 2 | |
| Completed |
NCT01382719 -
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
|
Phase 2 | |
| Not yet recruiting |
NCT06116045 -
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
|
Phase 2 | |
| Completed |
NCT05685407 -
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
|
Phase 1 | |
| Terminated |
NCT03682601 -
Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
|
Phase 2 | |
| Completed |
NCT01803802 -
Effects of Early Abuse on Adult Intimate Relationships
|
N/A |